Literature DB >> 8154454

The role of the microbiology laboratory in diagnosing mycobacterial diseases.

M Salfinger1, A J Morris.   

Abstract

Recent surveys show that many mycobacteriology laboratories continue to use less-than-optimal culture and susceptibility methods. This review summarizes available methods to diagnose. Mycobacterium tuberculosis. Although the local epidemiologic characteristics of M tuberculosis will partially determine what diagnostic measures are used, all laboratories should use a broth culture method in addition to a solid medium when culturing for M tuberculosis. Laboratories serving communities where drug resistance is common should use the BACTEC system for susceptibility testing or send isolates to a laboratory that uses it. Conventional testing in this setting must be aggressively discouraged. Rapid genetic amplification methods to detect mycobacteria in clinical specimens can greatly reduce the time needed to diagnose tuberculosis, especially if these methods can reliably detect M tuberculosis in smear-negative specimens. Many other diagnostic methods are being developed and clinicians and laboratories must regularly reassess whether a new method would be beneficial to their patients and the public.

Entities:  

Mesh:

Year:  1994        PMID: 8154454

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

Review 1.  Diagnosis of tuberculosis and other diseases caused by mycobacteria.

Authors:  M Salfinger
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

2.  Evidence of transmission of Mycobacterium tuberculosis by random amplified polymorphic DNA (RAPD) fingerprinting in Taipei City, Taiwan.

Authors:  H J Harn; K L Shen; L I Ho; K W Yu; G C Liu; K C Yueh; J H Lee
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

3.  Evaluation of two commercial amplification assays for detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  M Zolnir-Dovc; M Poljak; K Seme; A Rus; T Avsic-Zupanc
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.